Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANAPTYSBIO, INC Director's Dealing 2019

Sep 26, 2019

32596_dirs_2019-09-26_4be5a97d-cf7d-4df7-83c3-117ac1eb404d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ANAPTYSBIO, INC (ANAB)
CIK: 0001370053
Period of Report: 2019-09-24

Reporting Person: Hamill Laura (Director)

Holdings (Non-Derivative)

Security Shares Ownership
No securities beneficially owned 0 Direct